Beximco Pharma is a leading edge pharmaceutical company, based in Dhaka, Bangladesh and is acclaimed for outstanding product quality, world-class manufacturing facilities, product development capabilities and outstanding service. We produce and market branded generics for almost all diseases from AIDS to cancer, from infection to asthma, from hypertension to diabetes, for both national and international markets. We also manufacture active pharmaceutical ingredients and intravenous fluids and contract manufacture for major international brands of leading multinational companies. We partner our activities to the humanities quest for longer, healthier, and happier life. We employ more than 2,300 staff, including over 300 qualified specialists such as pharmacists, chemists, microbiologists, engineers. As a listed company, Beximco Pharma’s shares are traded on the London (LSE), Dhaka (DSE) and Chittagong (CSE) Stock Exchanges.